BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2016
View Archived Issues
ProMetic Life Sciences begins rolling submission of BLA for plasminogen
Read More
Phase I and phase II extension study results for fitusiran
Read More
Sage Therapeutics begins phase II program for SAGE-217 in mood disorders
Read More
Phase III study of closed triple combination therapy for asthma begins
Read More
Spring Bank and Arbutus to collaborate on preclinical studies of combination for HBV
Read More
FDA grants breakthrough therapy designation for TNX-102 SL
Read More
Circuit Therapeutics and Lundbeck enter research collaboration
Read More
Highly selective spleen tyrosine kinase inhibitor shows potential for autoimmune diseases
Read More
Topline results from an intranasal human abuse potential study of Egalet-002
Read More
FDA grants priority review to Tesaro's NDA for niraparib
Read More
Phase Ia/b data for chimeric fibril-reactive mAb 11-1F4 in patients with AL amyloidosis
Read More
Novel CD33-specific CAR T cells show promise in in vitro and in vivo models of AML
Read More
Novel forward-oriented therapeutic vector for hemoglobin disorders
Read More
JCAR-017 obtains FDA breakthrough therapy designation and EMA PRIME access
Read More
FDA grants fast track designation to ASP-0892
Read More
MediciNova's MN-166 granted orphan drug status in E.U. for ALS
Read More
GlaxoSmithKline patents KMO inhibitors
Read More
FDA accepts for review NDA for CCP-08
Read More
Sunshine Lake Pharma discloses 5-HT reuptake inhibitors and/or 5-HT1A receptor agonists
Read More
Rugen Holdings describes NR2B receptor antagonists
Read More
Teijin Pharma develops CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors
Read More
Jiangsu Tasly Diyi Pharmaceutical presents antiviral agents
Read More
FDA extends PDUFA date for Genentech's ocrelizumab
Read More
Janssen applies for approval of daratumumab in Japan
Read More
Diurnal submits European pediatric use marketing authorization application for Infacort
Read More
Apellis Pharmaceuticals' APL-2 earns fast track designation from FDA
Read More
Akebia and Otsuka Pharmaceutical collaborate to develop and commercialize vadadustat in the U.S.
Read More
Allergan to acquire LifeCell
Read More
FDA gives fast track designation to KemPharm's KP201/IR
Read More
Circadian Therapeutics formed as a new Oxford spinout to study sleep and circadian rhythms
Read More
